News|Articles|July 3, 2025

FDA news recap in urology for Q2 2025

Author(s)Hannah Clarke, Benjamin P. Saylor, Strategic Content Lead, Jason M. Broderick

Here’s a look back at notable news between April and June 2025.

The specialty of urology, following an eventful first quarter, had a busy Q2 with a flurry of FDA approvals (and 1 notable non-approval) ranging from benign prostatic hyperplasia (BPH) to urge incontinence to bladder cancer and prostate cancer.